In research-oriented clinical practice, the increased levels of CSF T-tau are sensitive for neurodegenerative tauopathies [17], and it has been shown that phosphorylated tau markers such as P-tau181 and P-tau217 are particularly specific for AD pathologic process [18]. This evidence concerns the gene MAPT and Alzheimer disease.